![Nathen Fuentes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nathen Fuentes
Director Financiero/CFO en TELOMIR PHARMACEUTICALS, INC. .
Fortuna: 611 861 $ al 31/05/2024
Cargos activos de Nathen Fuentes
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TELOMIR PHARMACEUTICALS, INC. | Director Financiero/CFO | 21/09/2023 | - |
Secretario Corporativo | 21/09/2023 | - | |
Treasurer | 21/09/2023 | - |
Historial de carrera de Nathen Fuentes
Antiguos cargos conocidos de Nathen Fuentes.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | Comptroller/Controller/Auditor | 01/01/2013 | 01/01/2017 |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/2012 | 01/01/2013 |
Formación de Nathen Fuentes.
University of Florida | Undergraduate Degree |
Fairfield University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Bélgica | 2 |
Operativa
Director of Finance/CFO | 5 |
Corporate Officer/Principal | 2 |
Corporate Secretary | 1 |
Sectorial
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
TELOMIR PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | Technology Services |
- Bolsa de valores
- Insiders
- Nathen Fuentes
- Experiencia